Ultragenyx Pharmaceutical, Inc. (RARE)
36.30
-0.15
(-0.41%)
USD |
NASDAQ |
Dec 09, 16:00
36.49
+0.19
(+0.52%)
After-Hours: 06:25
Ultragenyx Pharmaceutical EPS Diluted (Quarterly): -1.808 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Geron Corp. | -0.0276 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -180.41M |
| Revenue (Quarterly) | 159.93M |
| Total Expenses (Quarterly) | 340.35M |
| Enterprise Value | 3.937B |
| Gross Profit Margin (Quarterly) | 77.12% |
| Profit Margin (Quarterly) | -112.8% |
| Earnings Yield | -16.36% |
| Normalized Earnings Yield | -16.34 |